| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.07 | 0.3 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |